News : 2019

Dr. Mariano Kanamori, standing with his team working on “Finishing HIV: An HIV Protection, Diagnosis and Treatment Network for Latinos.”

UM Awarded Six NIH Grants for Innovative Strategies to End the HIV Epidemic

Six University of Miami collaborative studies to test new HIV treatment and prevention strategies have received supplemental funding grants totaling $912,000 from the National Institutes of Health as part of the nationwide initiative “Ending the HIV Epidemic: A Plan for America.”

Read more »

From left, Daniel Feaster, Ph.D., Steven Safren, Ph.D., and Deborah Jones Weiss, Ph.D., M.Ed.

New Mental Health Research Center Will Combat Miami’s AIDS Epidemic

The United Nations’ goal of ending AIDS around the world by 2030 is undeniably ambitious, but within tantalizing reach. Thanks to medications that suppress the once-fatal human immunodeficiency virus and prevent its transmission, new infections have dropped by nearly 50 percent over the past two decades.

Read more »

Provost’s Award for Scholarly Activity 2019

Life-changing discoveries and groundbreaking publications highlight only a portion of the work done by University of Miami faculty. Some faculty achievements are the result of a single matchless accomplishment, while others are the result of many years of dedication and inquiry. The annual Provost’s Award for Scholarly Activity (PASA) recognizes faculty on various scholarly paths who have demonstrated excellence in their field as researchers, gifted teachers, and mentors.

Read more »

AIDS vaccine using engineered herpesvirus works in monkeys

For the first time, scientists have used a genetically engineered herpesvirus to achieve significant vaccine protection against the AIDS virus in monkeys. Only live attenuated strains of simian immunodeficiency virus (SIV), the monkey version of HIV, have previously provided similar protection.

Read more »

New HIV Treatment Strategy Can Provide Long-term Viral Suppression, according to Miller School Study

A University of Miami Miller School research team has found a new approach to preventing and treating HIV infection in a preclinical model. With one injection of anti-HIV monoclonal antibodies, the researchers were able to suppress the virus for three years in one monkey and for extended periods in two others.

Read more »

Miller School of Medicine Sets New Record in NIH Research Grant Funding

The University of Miami Miller School of Medicine received a record $133.5 million in research grants from the National Institutes of Health in Federal Fiscal Year 2018 — a $12.8 million increase over the school’s FFY 2017 total, raising the school another point to No. 40 of 147 institutions in the national rankings.

Read more »

From left, Henri R. Ford, M.D., MHA, Emmanuel Thomas, M.D., Ph.D., and CTSI Director Ralph L. Sacco, M.D., MS.

Dean Henri R. Ford Launches Interdisciplinary Research Lecture Series

Emmanuel Thomas, M.D., Ph.D., a researcher at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was the inaugural speaker in Dean Henri R. Ford’s Interdisciplinary Research Lecture Series. Dr. Thomas’s lecture was titled “An Integrated, Multidisciplinary Approach for the Prevention and Early Detection of Viral Hepatitis-induced Hepatocellular Carcinoma.”

Read more »